Introduction
The renal effects of parathyroid hormone on Na coupledphosphate transport and Na/H exchange have been exten-crease both Na/H antiporter activity and Na coupled-phosphate transport. cAMP-mediated pathways are clearly important as effectors of PTH action, but several lines of evidence have suggested the possibility of other intermediaries. First, PTH increases intracellular calcium and causes phosphoinositide turnover in the OK cell (4) . Although recent evidence suggests that intracellular calcium is not a mediator of these effects, protein kinase C (PKC) activation may be required for the inhibition of transport (5) (6) (7) . Second, there is a several log order disparity between the concentrations of PTH required for half-maximal transport inhibition versus those needed for half-maximal cAMP generation (5, 6, 8) . This dissociation may, however, merely indicate that only a small increment in cAMP concentration is adequate to activate protein kinase A (PKA) for PTH-induced effect on transport to be manifest (9, 10) . Most studies of these relationships have used pharmacological inhibitors of cAMP generation (e.g., dideoxyadenosine) or of protein kinase C activation (e.g., prolonged phorbol ester incubation or staurosporine) to probe these mechanisms.
The effects ofcAMP are known to be mediated through the PKA system. PKA exists as a heterotetramer of two regulatory subunits (R' or R"'), which on binding two cAMP molecules per R unit dissociate from two catalytic units (C) (1 1). The C units, only active when dissociated from R, are then free to phosphorylate their target substrates. R and C subunits form a very high affinity tetramer and under normal circumstances the bulk of the catalytic units are complexed to R in the form R2C2, a state in which the catalytic C units are inactive (1 1). Many somatic mutations which disrupt cell PKA activity have been described and have been found to affect R units (12) (13) (14) (15) . Recently, McKnight et al. have cloned both the native mouse R' unit and several mutant R isoforms which had been isolated by Steinberg et al. ( 14, 16) . These mutations are characterized by decreased cAMP binding affinity to one or both of the two cAMP binding sites of R and consequently, a marked increase in the cAMP concentration needed to dissociate R from C and activate PKA (17) . Recent (16, 18) .
Herein we report an approach to dissect the importance of the PKA pathway in PTH action by DNA-mediated gene transfer of dominant cAMP resistance in OK cells. By overexpressing a mutant type I regulatory subunit of PKA (RI*), which is deficient in cAMP binding, phenotypic cAMP resistance was achieved in OK cells. The resulting 20 -fold reduction in the sensitivity of the PKA system to cAMP abolished the PTH and cAMP effects on Na-phosphate transport. These findings suggest that an intact and normally cAMP-sensitive PKA system is required for PTH to inhibit Na-phosphate cotransport in the OK cell.
Methods
Cell culture. A single cell clone ofOK cells which is responsive to PTH was the starting material for all studies. They were maintained in DME, 5% fetal bovine serum; 5% NuSerum (Collaborative Research, Inc., Bedford, MA); glucose, 5 g/liter, NaHCO3, 24 mM; Hepes, 12.5 mM; glutamine, 2 mM; penicillin, 100 U/ml; streptomycin, 100 jg/ml; in 5% CO2:95% air. Cells were passed weekly.
Transfection and selection. OK cells were transfected with pHLREV, an expression vector for the A or site I mutant ofthe mouse R' unit under the control of the Harvey sarcoma virus long terminal repeat (LTR), and pSV2NEO (100 and 5 zg, respectively). Transfection was done by electroporatior, as described by Chu (19) , and cells were selected in 800 ,g/ml ofG418 (20) . G418-resistant colonies were expanded, pooled, and frozen. Thereafter, cells used for experiments described were maintained in G418-free medium for at least three passages before experiments. This plasmid was provided by Dr. G. S. McKnight, Univ. of Washington, Seattle, WA, and was propagated, prepared, and purified by standard techniques (21).
Protein kinase A measurement. Cells were grown to confluence in 150-cm2 tissue culture dishes, washed three times with iced PBS, scraped from the plate, and centrifuged at 200 g for 3 min. The pellet was disrupted by freeze-thawing in MES (pH 7.4), 10 mM; EDTA, 1 mM; DTT, 1 mM; 1,10 phenanthroline, 1 mM; benzamidine, 1 mg/ml; PMSF, 0.2 mM; acid-washed charcoal, 2 mg/ml. The homogenate was centrifuged at 100,000 g for 1 h at 40C. PKA activity in the cytosolic supernatant was measured by the phosphorylation of the synthetic substrate Kemptide (Leu-Arg-Arg-Ala-Ser-Leu-Gly; Peninsula Laboratories, Inc., Belmont, CA) (22, 23 I MCi/ml. Uptake medium "B" was identical, except for N-methyl-D-glucamine replacing Na. Cells were washed and then incubated briefly at 370C on a heating pad with preuptake medium "C" (equivalent to "B" without P04). After this, medium was replaced with either solution A (+Na), or solution B (-Na). After 10 min, uptake was terminated by washing five times with 4°C MgCl2, 0.1 M; and Hepes (pH 7.4), 1 mM. The wells were aspirated and the remaining contents were dissolved in 0.1% SDS overnight. Aliquots were counted for 32P as well as protein measurement. The Na-independent uptake was subtracted from all other values. Uptake was calculated as nanomoles phosphate/mg protein per unit time. Preliminary experiments indicated that Na-phosphate cotransport was linear for > 15 min using these protocols.
cAMP generation. Cells were grown to confluence in multiwell clusters as previously described. They were incubated with DME buffered with 25 mM Hepes (pH 7.4) and containing I mg/ml bovine serum albumin at 37°C in C02-free air for 1 h. The medium was then replaced with PTH-containing medium (0.1-1,000 nM) also containing I mM IBMX. After 5 min incubation, cells were washed with iced PBS, and I ml absolute ethanol was added. After 1 h at 4°C the ethanol was transferred to microcentrifuge tubes and centrifuged at 43,000 g. The supernatant was evaporated to dryness in a Speedvac (Savant Instruments, Inc., Hicksville, NY). Dried samples were reconstituted and cAMP was assayed by competitive protein binding using a kit (Amersham Corp., Arlington Heights, IL).
Measurement of diacylglycerol content. Cells were grown in 150-cm2 dishes to confluence and gently scraped from the plates, rinsed three times in Hepes-buffered DME containing I mg/ml fatty acid-free bovine serum albumin, and resuspended in the same medium at the approximate ratio of 150-cm2 growing area/0.5 ml. 200 Ml of cell suspension was added to 100 Ml medium with or without 300 nM PTH in a microcentrifuge tube at 37°C. After 10 s200 Ml of this suspension was removed and pipetted into 800 Ml of chloroform:methanol: 1 M HCI (2:1:. 1). A parallel sample was centrifuged, the cell pellet dissolved in 0.1% SDS, and protein determined. Quantitative lipid extraction and determination of diacylglycerol with Escherichia coli diacylglycerol kinase was performed as described by Preis et al. (24) . Results were expressed as pmol/mg protein.
Phosphoinositide turnover. Cells were incubated for 72 h in inositol-free medium containing 10 MCi/ml of 3H-myo-inositol. The medium was supplemented with 10% fetal bovine serum which had been dialyzed against PBS. Cells were then exposed to 100 nM PTH for 45 s or 5 min. The exposure was terminated by aspiration of medium and addition of 10% TCA. After centrifugation for S min at 10,000 g, the supernatant was extracted six times with diethyl ether. The resultant solution was neutralized to pH 6-7 with 0.15 M NH40H, and applied to Dowex resin in the formate form in disposable columns. IP2 and IP3 were separated by eluting with increasing concentrations of ammonium formate in 100 mM formic acid. Scintillation counting was performed on all fractions. Proteins were measured from cell pellets dissolved ip 0.1% SDS using the BCA protein assay reagent (Pierce). (OK-HL) were selected in G4 18 and resistant colonies pooled and frozen at early passage. Parallel cultures transfected with only 100 ,ug of pSV2NEO acquired stable G418 resistance at a frequency of -5 X 10-4. Transfected cells displayed some morphological differences under phase microscopy and grew at a slower rate than wild type OK cells (OK-wt).
Results

Characterization
The cAMP sensitivity of PKA in OK-wt and OK-HL cells was determined in order to demonstrate that phenotypic cAMP resistance was achieved. The sensitivity of PKA in the cytoplasmic fraction of wild type OK cells (OK-wt) and OK-HL cell homogenates is shown in Fig. 1 where NH is the Hill coefficient and pK is the log of an arbitrary coefficient. The log ofthe cAMP concentration for half-maximal activity is given as -pK/NH. The data were fitted to this logarithmic transformation of the Hill equation using the program MINSQ. tuted in vitro from purified catalytic and either R' or RJ* units have been determined to be 1.58 and 0.58, respectively (17) .
To further characterize the difference in the bulk PKA population, cell extracts from OK-wt and OK-HL cells were chromatographed on DEAE cellulose and eluted with a NaCl gradient. Under these conditions only the intact R2C2 tetramer is recovered by salt elution (13, 25) . It can resolve type I from type II PKA, known mutants of R', and has been used to resolve the partial cAMP-bound from cAMP-free PKA. Fig. 2 shows the elution profile of PKA activity. OK-wt cell PKA activity eluted as a single broad peak between 0.13-0.2 M NaCl. In contrast, OK-HL cell PKA eluted at a higher concentration (0.2-0.26 M NaCl). These findings are consistent with a change in the ion exchange properties of the PKA holoenzyme: virtually all of the intact PKA holoenzymecontaining R subunits differed in ion exchange properties from the wild type.
A direct demonstration of coexpression of normal and mutant R' units was done by photoaffinity labeling RI subunits with 8-azido-[32P]cAMP and resolving the labeled products by two-dimensional gel electrophoresis (26, 27) . RI, the dominant species in the OK cell, represents the bulk of the cAMP binding activity in the OK cell. It can be visualized in two forms of slightly differing isoelectric point in the upper panel of Fig. 3 , migrating at -48 kD. These two forms represent the non and autophosphorylated forms of R' (14, 15) . In addition, two lower molecular weight forms, -31 kD, are present and probably represent a well defined proteolytic product of R (28) . This proteolytic fragment is characterized as retaining the two cAMP binding sites and is therefore labeled by the photoaffinity probe. Photoaffinity labeling of an equal amount of OK-HL extract is shown in the lower panel of Fig. 3 . This gel demonstrates the presence of R' and its phosphorylation product, in addition to another set of labeled proteins, migrating -_ 0.5-pH units more alkaline but at the same molecular weight. This represents the mutant RI*. The alkaline pH shift is comparable to that described by Steinberg et al., who developed the cAMP-resistant S49 lymphoma cells from which this RI* was cloned (14) . Direct two-dimensional surface scintillation counting over the dried gel with an AMBIS counter was holoenzyme from DEAE cellulose. Homogenates from OK-wt and OK-HL cells were prepared as described, applied to a DEAE cellulose column, and eluted with a 0-0.4 M NaCl gradient. Equal amounts of each fraction were assayed directly for protein kinase A activity as described. The solid and dotted lines represent elution profiles for OK-wt and OK-HL cells, respectively. performed. The R'* area contained 9.8-fold the 32p counts as the native R' area. Since the RI* has only one functional cAMP binding site (12, 17) , the other having been destroyed by mutation, analysis of this gel indicates a 19.6-fold overexpression of R'* compared to the native R'.
Finally, we measured the increase in PKA activity ratio (9) in both OK-wt and OK-HL cells with and without 100 nM PTH. The PKA activity ratio is the ratio of kinase activity in the absence of added cAMP divided by that in the presence of maximal cAMP. As such, when in the absence and presence of an agonist, it gives an estimate of how much dissociation of PKA has occurred as a result of addition of an agonist. The PKA ratio in OK-wt cells increased 67% after 1 h of 100 nM PTH exposure. In OK-HL cells, the activity ratio increased only 11% after the same PTH treatment. Therefore, similar PTH concentrations induced a much larger dissociation of PKA in the OK-wt cells than the OK-HL line, supporting the contention of relative cAMP resistance.
In summary, these data demonstrate that: (a) R'* was 20-fold overexpressed relative to the native R' unit; (b) the overexpressing cells demonstrated intact PKA in which the bulk ion-exchange properties were altered, indicating that almost all of the PKA contained a mutant RI* unit; (c) the cAMP-dependence of activation of PKA was shifted to the "right," 20-fold less sensitive to cAMP and less cooperative with respect to cAMP binding; and (d) the total PKA activity at maximal cAMP concentration was relatively preserved. Therefore, the phenotype of the transfected OK-HL population is that expected from dominant expression ofthe RI* unit. In this sense dominant indicates that although a normally cAMP-sensitive R' unit was present, the observed cAMP sensitivity was that characteristic ofthe less cAMP-sensitive mutant R'* unit. Therefore, the overexpression is phenotypically dominant (15, 16) . Having induced relative cAMP resistance, we evaluated the effect of agonists on Na-phosphate cotransport.
Effects of cAMP-insensitive PKA on PTH-and cAMP-induced inhibition ofNa-phosphate cotransport. Preliminary experiments indicated that the PTH effect to decrease Na-phosphate cotransport was maximal between 3 and 4 h, and therefore all experiments were done at 4 h. OK-wt and OK-HL cells were exposed to PTH, 1 mM cAMP, 250 sg/ml oleoyl-acetyl glycerol (OAG), or l-7 M phorbol myristate acetate (PMA) after which Na-phosphate cotransport was measured. Fig. 4 (top) shows the effect of these agonists on Na-phosphate cotransport in OK-wt cells. PTH produced a dose-dependent inhibition of Na-phosphate cotransport with maximal inhibition of 28% of transport occurring at 1,000 nM PTH and half-maximal inhibition between 1 and 10 nM. The maximal concentrations of cyclic AMP, OAG, and PMA used in these studies each decreased Na-phosphate cotransport by over 50%. In contrast, the responses of OK-HL cells to maximal concentrations of these agonists is shown in Fig. 4 (bottom). In these cells, expressing a dominant cAMP-resistance mutation, there was no effect of 1 concentrations of PTH (data not shown) also had no effect on Na-phosphate cotransport. In other experiments OK-HL cells were exposed to maximal concentrations of cAMP or PTH for 6 h without an inhibition of Na-phosphate cotransport. OAG and PMA did decrease Na-phosphate cotransport significantly, but with a smaller effect than in the OK-wt cells. In postulating that we had interrupted PTH effect by expressing this mutation, it was necessary to demonstrate that the OK-HL population had PTH receptor coupled to adenylate cyclase. Fig. 5 shows the cell cAMP content of OK-wt and OK-HL cells 5 min after addition of increasing PTH concentrations. The cAMP-generation curves ofboth populations are comparable with a half-maximal cAMP production between 1 and 10 nM. The kinetics of Na-phosphate cotransport were also determined. At 100 mM external Na, the Km for phosphate was 99 and 131 uM for phosphate in OK-wt and OK-HL cells, respectively; the Vm. was also comparable. Therefore, the Na-phosphate cotransporter appeared to be similar in both cell types with respect to external phosphate kinetics and maximal transport activity.
Role of activators of PKC and Ca, in the PTH-induced alterations in Na-phosphate cotransport. Both OAG and protein kinase C-activating phorbol esters have been shown to decrease Na-phosphate cotransport in the OK cell suggesting that activation of PKC could play a role in this PTH action. PTH exposure has been shown in some studies to increase the release of labeled inositol Tris phosphate (IP3) and diacylglycerol over a short (30 10 MCi/ml 3H-myoinositol for 72 h in inositol-free medium containing 10% dialyzed fetal bovine serum. After labeling, cells were exposed to PTH (1 gM) for 45 s and 5 min followed by inactivation with trichloroacetic acid. The content of 3H activity coeluting with IP2 and IP3 was determined by ion exchange chromatography. In both the OK-wt and OK-HL cells, we were unable to determine a change in the 3H elution profile with PTH treatment of either 45 s or 5 min. In several experiments, we found no PTH-induced increment in IP2 or IP3 release in either the clonally derived OK-wt cells or in the OK-HL transfectants.
PTH has also been reported to be accompanied by a small increase in intracellular calcium in the OK cell. This presumably arises via an IP3-mediated mechanism. However, recent evidence suggests that changes in Na-phosphate cotransport occur independently of these fluxes. Even though we were unable to measure an IP3 increment, we determined whether a calcium flux was retained in these cells. OK-wt cells and OK-HL cells were grown on glass coverslips and intracellular calcium (Caj) was directly measured by fura II fluorescence (29) . In OK-wt cells addition of 100 nM PTH produced an The transfection-mediated overexpression of the mutant RI* subunit proved to be unstable over extended passages. We initially elected not to isolate single cell subclones of transfected cells because previous experiments (data not included) involving expression of other exogenous genes in OK cells had demonstrated that loss of expression occurred over a similar number of passages when no selective pressure for expression existed. This was found to be true both in whole populations and single-cell subclones. In addition to loss of expression related to the instability of transfected genes, the cAMP-resistant phenotype would seem to be disadvantaged because of a slower growth rate than the wild type. The later passages of revertant OK-HL cells remained resistant to G4 18, the selection for the cotransfected NEO marker, yet expression of the mutant phenotype was lost. This emphasizes that the overexpressed RI* phenotype was selectively disadvantaged over the wild type, probably because of its slower growth rate. (9) . These authors determined the relationship between inhibition of Na-phosphate cotransport and the PKA activity ratio in response to PTH and antagonists of PTH action. The PKA activity ratio (the ratio between free catalytic C activity and inactive but recruitable R2C2) is a measure of the degree of "activation" of PKA by cAMP. They used 2',5'-dideoxyadenosine (DDA), an inhibitor of cAMP formation, and 3-34-[Nle8, Nle'8, Tyr34]bPTH amide (3-34-bPTH), a PTH analogue that results in no measurable cAMP formation. These authors determined that inhibition of Na-phosphate cotransport was unrelated to the amount of intracellular cAMP generated in response to agonists but was proportional to the alteration in PKA activity ratio, the degree of activation of PKA. Using PTH plus DDA or 3-34-bPTH alone, PKA was clearly activated in the presence of reduced or unmeasurable increments of cAMP generation. The finding of this study was that there was cAMP effect in the absence of large or detectable changes in intracellular cAMP. In this setting, PKA activation is likely to be more reflective of the effect of intracellular cAMP than is the measurement of the cAMP level itself. Accordingly, these authors suggest that a PKA-independent mechanism need not be invoked to explain the disparity between dose-response curves for cAMP generation and for inhibition of Na-phosphate cotransport.
Protein kinase C or intracellular calcium mediation of PTH effects has been suggested for several reasons. PTH produces a small, rapid turnover of IP3 and diacylglycerol release in OK cells associated with a small intracellular calcium transient (4-7). Further, a brief activation of PKC, measured as a partition from soluble to membrane-bound form, has been reported to occur seconds after addition of PTH to OK cells (32) . In some studies, an increase in IP3 turnover and release of diacylglycerol are evident at sub-nanomolar PTH concentrations, below those at which an elevation of cAMP content is present. (Although we found a significant increase in total DAG after PTH, it should be noted that we found no increment in IP3 release and that other laboratories have also had difficulty in demonstrating this effect [Dr. R. A. Nissenson, UCSF, personal communication]). Since partial inhibition of Na-phosphate cotransport is evident at these low PTH concentrations, it has been suggested that PKC is the primary mediator of PTH inhibition of Na-phosphate cotransport and the role of PKA has been questioned (5) .
While there is no question that activators of protein kinase C (phorbol esters and permeable diacyl glycerol) inhibit Naphosphate cotransport in the OK cell, the evidence that PKC activation is necessary for the PTH effect is based on two less convincing observations. Quamme et al. (6) noted that staurosporine, a fungal protein kinase inhibitor, abolished the PTH effect on Na-phosphate cotransport in a dose-related manner and attributed this to inhibition of PKC, based on staurosporine's greater specificity for PKC. However, the primary data in the literature suggest that staurosporine is a relatively nonselective inhibitor ofboth PKA and PKC; the Ki ofstaurosporine for PKA and PKC differs by less than an order of magnitude (33, 34) . At the concentrations reported, both PKA and PKC would be inhibited. Therefore, staurosporine does not seem a useful probe to differentiate the action of these two kinases.
In the same report, it was found that PKC downregulation by prolo~nged phorbol ester incubation rendered the OK cell Na-phosphate cotransporter insensitive to all agonists including PTH, cAMP, and phorbol ester rechallenge. This finding indicates that an intact PKC pathway is needed for modulation of Na-phosphate cotransport by PTH, cAMP, and, trivially, activators of PKC. However, rather than acting as a pharmacological or kinetic inhibitor, phorbol ester downregulation of PKC is associated with marked absolute loss of most PKC activity and protein (35, 36) . As noted by these authors, this maneuver does not separate the necessity for PTH-induced PKC activation from the need for a basal level ofPKC activity. The intervention described in this study is the induction of a decrease in the cAMP sensitivity of PKA by expression of a cAMP-insensitive PKA regulatory unit. We pursued this approach to avoid some of the ambiguities inherent with the use of pharmacological kinase inhibitors. The nature of the overexpressed RI* subunit and the phenotype of the resultant PKA reported herein was fortuitous; even though the mutant RI* unit was overexpressed and the cAMP-sensitivity of PKA reduced, the total PKA activity (at maximal cAMP) was relatively preserved. The mechanisms of cAMP insensitivity presumably reflect several features of PKA biology. First, since the mutant RI* was 20-fold overexpressed relative to wild type R', it was likely that most of the R2C2 tetramers would contain the mutant. This suggestion is borne out by the ion exchange elution profile of intact PKA reported. This degree of overexpression may not have been necessary to attain this effect. S49 lymphoma mutants with allelic expression of equal amounts of normal and defective R units also express decreased kinase activity (15 for cAMP we measured in vitro and the decrease in cooperativity of activation, it is possible that even high concentrations of PTH did not induce a sufficient rise in cell cAMP to activate the mutant PKA. Second, the degree of overexpression of RI* relative to the native R' is estimated to be 20-fold. In normal cells R and C are expressed in roughly equal proportions. In the OK-HL cell population reported here, the overexpression of RI* was unaccompanied by an overexpression of C as evidenced by the roughly normal total PKA activity measured at maximal cAMP concentrations. Therefore there was probably a large pool of free RI* units capable of reforming stable complexes with C, making the release of free C (the cAMP effector) less likely.3 Thus the mutant cells described herein retained potential PKA activity while demonstrating relative cAMP resistance. This is in contrast to the maneuver of PKCinhibition phorbol ester downregulation; a setting in which almost all potential PKC activity is lost from the pool of recruitable kinase.
There is a large literature dealing with interactions of the PKA and PKC-signaling pathways and precedent is available for virtually every permutation of interaction. Many of these events involve PKA inhibition of PKC effect and vice versa (38) (39) (40) . More germane to the present studies are several examples in which activation of either PKA or PKC may independently produce the same or similar biological effect without an absolute requirement for activation of the complementary pathway (41) (42) (43) (44) (45) (46) . PTH inhibition of Na-phosphate cotransport in the OK cell may represent a situation in which two distinctly controlled kinase activities produce the same biological effect. In summary, exogenous agonists that directly and specifically activate either PKA or PKC result in an inhibition of OK cell Na-phosphate cotransport supporting the contention that two potential mechanisms for this effect exist in the OK cell. The finding that in transfected, cAMP-resistant cells Na-phosphate cotransport is unresponsive to maximal levels of cAMP and a range of PTH concentrations suggests that an intact and normally cAMP-sensitive PKA pathway is an absolute requirement for the PTH effect on Na-phosphate cotransport. Loss of the cAMP-resistant phenotype with repeated passage was associated with a return ofcAMP and PTH sensitivity, strongly suggesting that the perturbation of the PKA system was responsible for these effects. Definition ofthe independent role, ifany, of PKC in the PTH action on OK cell Na-phosphate cotransport was not unequivocally determined by these studies and must await the availability of more specific tools.
